Initial Experience of Sorafenib Neoadjuvant Therapy Combined with Retroperitoneoscopy in Treating T2 Large Renal Carcinoma

Objectives. To investigate the safety and feasibility of sorafenib neoadjuvant therapy combined with retroperitoneoscopic radical nephrectomy (RRN) in treating T2 large renal cell carcinoma (RCC). Methods. Retrospectively analyzed 5 cases (2 males and 3 females, aged 52–73 years) of T2 stage large R...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chun-hua, Yuan, He-jia, Wang, Ke, Wu, Ji-tao, Liu, Qing-zuo, Yu, Sheng-qiang, Men, Chang-ping, Gao, Zhen-li, Wang, Jiahui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573231/
https://www.ncbi.nlm.nih.gov/pubmed/26421296
http://dx.doi.org/10.1155/2015/609549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573231/
https://www.ncbi.nlm.nih.gov/pubmed/26421296
http://dx.doi.org/10.1155/2015/609549

Ejemplares similares